HC Wainwright & Co. Initiates Coverage of Processa Pharmaceuticals (PCSA) with Buy Recommendation

1d ago, source: Fintel on MSN

Fintel reports that on April 25, 2024, HC Wainwright & Co. initiated coverage of Processa Pharmaceuticals (NasdaqCM:PCSA) ...

Insider Buyers At Processa Pharmaceuticals Recover Some Losses, But Still Down US$40k

20d ago, source: Yahoo Finance

Insiders who bought US$210.6k worth of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) stock in the last year recovered part of their losses as the stock rose by 18% last week. However, total losses ...

Processa Pharmaceuticals Inc.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Tinygemsbreaks Processa Pharmaceuticals Inc. (NASDAQ: PCSA) To Present At Upcoming Medinvest Conference

29d ago, source: Mena FN

To view the full press release, visit About Processa Pharmaceuticals Inc. Processa is a clinical stage pharmaceutical company focused on developing the Next Generation Chemotherapy (“NGC ...

Processa Pharmaceuticals (PCSA) Earnings Dates & Reports

1mon ago, source: Investing

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial

16d ago, source: Stockhouse

HANOVER, Md., April 11, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage ...

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

29d ago, source: ADVFN

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to ...

Processa Pharmaceuticals Inc (PCSA)

15d ago, source: Investing

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic ...

Biomednewsbreaks Processa Pharmaceuticals Inc. (NASDAQ: PCSA) To Present At Upcoming Medinvest Conference

29d ago, source: Mena FN

To view the full press release, visit About Processa Pharmaceuticals Inc. Processa is a clinical stage pharmaceutical company focused on developing the Next Generation Chemotherapy (“NGC ...

Insider Buyers At Processa Pharmaceuticals Recover Some Losses, But Still Down US$40k

19d ago, source: Yahoo Finance

Insiders who bought US$210.6k worth of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) stock in the last year recovered part of their losses as the stock rose by 18% last week. However, total losses seen ...